Controlled-release ACE inhibitor - Servier
Latest Information Update: 01 Feb 2017
At a glance
- Originator Servier
- Class Small molecules
- Mechanism of Action ACE inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 17 Dec 2007 Phase-II clinical trials in Heart failure in France (PO)
- 11 Oct 2002 Investigation in Heart failure in France (PO)